Skip to main content
Log in

Community Impact of Anticoagulation Services: Rationale and Design of the Managing Anticoagulation Services Trial (MAST)

  • Published:
Journal of Thrombosis and Thrombolysis Aims and scope Submit manuscript

Abstract

We describe the design of the Managing Anti-coagulation Services Trial (MAST), a practice-improvement trial testing whether anticoagulation services are a preferred method of managing anticoagulation for stroke prevention among patients with atrial fibrillation. Most randomized trials within the health care environment are designed as efficacy studies to determine what works under ideal conditions or ideal clinical practice. In contrast, effectiveness trials seek to generalize the results of efficacy studies by determining what works under more typical practice conditions. Practice-improvement trials are effectiveness trials that examine the management of a clinical problem in the context in which care is usually given. Noteworthy features of the MAST include defining the intervention in functional terms and collaboration with managed care organizations.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

Reference

  1. Feinberg WM, Blackshear JL, Laupacis A, et al. Prevalence, age distribution, and gender of patients with atrial fibrillation. Arch Intern Med 1995;155: 469-473.

    Google Scholar 

  2. Matchar DB, McCrory D, Barnett H, Feussner JR. Medical treatment for stroke prevention. Ann Intern Med 1994;121:41-53.

    Google Scholar 

  3. Hirsh J, Dalen JE, Deykin D, Poller L. Oral anticoagulants: Mechanism of action, clinical effectiveness, and optimal therapeutic range. Chest 1992;102:312S-326S.

    Google Scholar 

  4. Stafford RS, Singer DE. National patterns of warfarin use in atrial fibrillation. Arch Intern Med 1996;156: 2537-2541.

    Google Scholar 

  5. Matchar DB, Samsa G, Bonito AJ, Witter D. Use of anticoagulation to prevent strokes: Results from an outpatient chart audit (abstr). J Gen Intern Med 1996;Vol. no. 7,Suppl. 1 126.

    Google Scholar 

  6. Ellis RF, Stephens MA, Sharp GB. Evaluation of a pharmacy-managed warfarin monitoring service to coordinate inpatient and outpatient therapy. Am J Hosp Pharm 1992;49:387-394.

    Google Scholar 

  7. Landefeld CS, Anderson PA. Guideline-based consultation to prevent anticoagulation-related bleeding: A randomized, controlled trial in a teaching hospital. Ann Intern Med 1992;116:829-837.

    Google Scholar 

  8. Seabrook GR, Karp D, Schmitt DD, Bandyk DF. An outpatient anticoagulant protocol managed by a vascular nurse-clinician. Am J Surg 1990;160:501-505.

    Google Scholar 

  9. Hall J, Radley AS. A role for community pharmacists in the control of anticoagulant therapy. Pharma J 1994;252:230-232.

    Google Scholar 

  10. Radley AS, Hall J. The establishment and evaluation of a pharmacist-developed anticoagulant therapy. Pharma J 1994;252:91-92.

    Google Scholar 

  11. Kornblit P, Senderoff J, Davis-Erickson M, Zenk J. Anticoagulation therapy: Patient management and evaluation of an outpatient clinic. Nurse Practitioner 1990;15:21-32.

    Google Scholar 

  12. Van der Meer FMJ, Rosnedaal FR, Vandenbroucke JP, Briet E. Bleeding complications in oral anticoagulant therapy: An analysis of risk factors. Arch Intern Med 1993;153:1557-1562.

    Google Scholar 

  13. Hirsh J, Dalen JE, Deykin D, et al. Mechanism of action, clinical effectiveness, and optimal therapeutic range. Chest 1995;108:231s-246s.

    Google Scholar 

  14. Matchar DB, Samsa GP, Cohen SJ. Should we just let the anticoagulation services do it? J Gen Intern Med 1996;11:768-770.

    Google Scholar 

  15. Beyth RJ, Antani MR, Covinsky KE, et al. Why isn't warfarin prescribed to patients with nonrheumatic atrial fibrillation? J Gen Intern Med 1996;11:721-728.

    Google Scholar 

  16. Sackett DL, Rosenberg WM, Gray JA, et al. Evidence-based medicine: What it is and what it isn't. Br Med J 1996;312:71-72.

    Google Scholar 

  17. Cohen SJ, Halvorson HW, Gosselink CA. Changing physician behavior to improve disease prevention. Prev Med 1994;23:284-291.

    Google Scholar 

  18. Davis DA, Thomson Ma, Oxman AD, Haynes RB. Changing physician performance: A systematic review of the effect of continuing medical education strategies. JAMA 1995;274:700-705.

    Google Scholar 

  19. Dietrich AJ, Woodruff CB, Carney PA. Changing office routines to enhance preventive care. Arch Fam Med 1994;3:176-183.

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Matchar, D.B., Samsa, G.P., Cohen, S.J. et al. Community Impact of Anticoagulation Services: Rationale and Design of the Managing Anticoagulation Services Trial (MAST). J Thromb Thrombolysis 9 (Suppl 1), 7–11 (2000). https://doi.org/10.1023/A:1018722001817

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1023/A:1018722001817

Navigation